Marcel Verheij, MD, PhD, discusses the use of chemotherapy vs CRT-containing strategies as a preferred preoperative regimen for resectable gastric cancer.
Marcel Verheij, MD, PhD
Advertisement
Marcel Verheij, MD, PhD is the Head of Department at Radboud University Medical Centre.
Articles by Marcel Verheij, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Priority Review to Gedatolisib for HR+, HER2-Negative Advanced Breast Cancer
2
Legubicin More Than Doubles PFS in Advanced Soft Tissue Sarcoma
3
Adjuvant CDK4/6 Inhibitors Gain Ground as Oral SERDs Emerge to Tackle Endocrine Resistance in Early HR+ Breast Cancer
4
Gamgertamig Nets FDA Fast Track Designation in Autoimmune Hemolytic Anemia and Immune Thrombocytopenia
5